Electronic Reporting Systems for Adverse Drug Reactions(ADRs).

General
, ,
1

An Electronic Reporting System is a digital platform that allows healthcare professionals, patients, and pharmaceutical companies to report ADRs quickly and efficiently. These systems replace paper-based reporting, improving speed, accuracy, and accessibility.

Purpose of Electronic ADR Reporting

  • Early Detection
  • Data Collection
  • Safety Monitoring
  • Regulatory Compliance

Key Features

  1. Online forms are available for reporting ADRs.
  2. Automatic validation and alerts are provided.
  3. It includes secure and confidential data handling.
  4. Ability to generate reports and statistics.
  5. Integration with national and global pharmacovigilance databases.

Examples of Electronic ADR Reporting Systems

  • VigiFlow – Managed by the WHO for global ADR reporting.
  • MedWatch – FDA’s reporting system in the United States.
  • Pharmacovigilance Programme of India (PvPI) – India’s official ADR reporting portal.
  • EudraVigilance – European Medicines Agency’s system for monitoring ADRs.

Advantages

  1. It is faster and easier reporting than paper-based systems.
  2. It reduces the errors in data entry.
  3. It enhances communication between healthcare providers and regulators.
  4. It helps in timely action on dangerous drugs.

Challenges

  1. There is lack of awareness among healthcare professionals and patients.
  2. Lack of Internet and technological barriers in remote areas.
  3. Underreporting of ADRs.
  4. ADR’s are not reported due to the concerns about data privacy and security reasons.

“How do these systems contribute to drug safety monitoring?”

MBH/PS